FilingReader Intelligence

Fermenta Biotech secures patent for plant-based vitamin D3 process

September 12, 2025 at 07:59 AM UTCBy FilingReader AI

Fermenta Biotech Limited, a manufacturer of APIs and nutritional premixes, announced on September 12, 2025, that the Indian Patent Office has granted a patent for its proprietary plant-based vitamin D3 manufacturing process. This in-house developed process strengthens Fermenta's intellectual property portfolio and reinforces its position in sustainable vitamin D3 solutions.

The new patent highlights Fermenta's commitment to vegan and vegetarian-friendly nutritional ingredients, addressing a growing global demand for ethically sourced and sustainable nutrition. This innovation is expected to open new opportunities in nutraceutical and food fortification sectors where plant-derived ingredients command premiums and increasing market share.

Prashant Nagre, managing director of Fermenta, stated that this patent reflects the company's dedication to environmentally conscious solutions and is a proud milestone in its innovation journey. The development diversifies Fermenta's legacy in biotechnology and nutrition, supporting its vision to tackle global nutrition gaps while maintaining scientific excellence and sustainability leadership.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

BSE:FERMENTABombay Stock Exchange

News Alerts

Get instant email alerts when FERMENTA BIOTECH publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →